These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8994876

  • 1. Control by phosphorylation.
    Johnson LN, O'Reilly M.
    Curr Opin Struct Biol; 1996 Dec; 6(6):762-9. PubMed ID: 8994876
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A protein phosphorylation switch at the conserved allosteric site in GP.
    Lin K, Rath VL, Dai SC, Fletterick RJ, Hwang PK.
    Science; 1996 Sep 13; 273(5281):1539-42. PubMed ID: 8703213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evolution of allosteric control in glycogen phosphorylase.
    Hudson JW, Golding GB, Crerar MM.
    J Mol Biol; 1993 Dec 05; 234(3):700-21. PubMed ID: 8254668
    [Abstract] [Full Text] [Related]

  • 6. Electrostatic effects in the control of glycogen phosphorylase by phosphorylation.
    Johnson LN, Barford D.
    Protein Sci; 1994 Oct 05; 3(10):1726-30. PubMed ID: 7849589
    [Abstract] [Full Text] [Related]

  • 7. The effects of phosphorylation on the structure and function of proteins.
    Johnson LN, Barford D.
    Annu Rev Biophys Biomol Struct; 1993 Oct 05; 22():199-232. PubMed ID: 8347989
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The amino-terminal tail of glycogen phosphorylase is a switch for controlling phosphorylase conformation, activation, and response to ligands.
    Biorn AC, Graves DJ.
    Biochemistry; 2001 May 01; 40(17):5181-9. PubMed ID: 11318640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP, Withers SG, Ermert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN.
    Biochemistry; 1996 Jun 11; 35(23):7341-55. PubMed ID: 8652510
    [Abstract] [Full Text] [Related]

  • 14. Access to phosphorylation in isocitrate dehydrogenase may occur by domain shifting.
    Finer-Moore J, Tsutakawa SE, Cherbavaz DR, LaPorte DC, Koshland DE, Stroud RM.
    Biochemistry; 1997 Nov 11; 36(45):13890-6. PubMed ID: 9374867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural relationships among regulated and unregulated phosphorylases.
    Buchbinder JL, Rath VL, Fletterick RJ.
    Annu Rev Biophys Biomol Struct; 2001 Nov 11; 30():191-209. PubMed ID: 11340058
    [Abstract] [Full Text] [Related]

  • 19. Purification and crystallization of glycogen phosphorylase from Saccharomyces cerevisiae.
    Rath VL, Hwang PK, Fletterick RJ.
    J Mol Biol; 1992 Jun 20; 225(4):1027-34. PubMed ID: 1613787
    [Abstract] [Full Text] [Related]

  • 20. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG, Tsitsanou KE, Zographos SE, Skamnaki VT, Goldmann S, Bischoff H.
    Protein Sci; 1999 Oct 20; 8(10):1930-45. PubMed ID: 10548038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.